Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients"
- PMID: 32978701
- DOI: 10.1245/s10434-020-09170-6
Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients"
Comment on
-
Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients.Ann Surg Oncol. 2020 Dec;27(Suppl 3):940-941. doi: 10.1245/s10434-020-09167-1. Epub 2020 Sep 28. Ann Surg Oncol. 2020. PMID: 32989657 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical